← Back
$TOI All transactions

Oncology Institute, Inc.

▼ SELL 10b5-1 Plan

$ Value

$201K

Shares

57,286

Price

$4

Filed

Apr 16

Insider

Name

Kaushal Mohit

Title

CIK

0001683021

Roles

Director

Transaction Details

Transaction Date

2026-04-14

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

211,016

Footnotes

Represents shares sold pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 16, 2025. | Price of $3.5017 was the volume weighted average selling price of all sales by the reporting person on April 14, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5300. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price. | Price of $3.5005 was the volume weighted average selling price of all sales by the reporting person on April 16, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5050. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Filing Info

Accession No.

0001079973-26-000499

Form Type

4

Issuer CIK

0001799191

Kaushal Mohit's History

Date Ticker Type Value
2026-04-16 TOI $135K
2026-04-14 TOI $201K

Other Insiders at TOI (90d)

Insider Bought Sold Last
Chernett Jorey $689K 2026-04-09
Kaushal Mohit $135K 2026-04-16
Podnos Yale
Chief Medical Officer
2026-03-27
Virnich Daniel
Chief Executive Officer
2026-03-27
Carter Robert Ross
Chief Financial Officer
2026-03-27
Langsam Jeffrey
Chief Clinical Officer
2026-03-27
England Kristin
Chief Administrative Officer
2026-03-27